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Abstract
22q11.2 Deletion Syndrome (22q11DS) arises from an interstitial chromosomal microdeletion encompassing at least
30 genes. This disorder is one of the most significant known cytogenetic risk factors for schizophrenia, and can also
cause heart abnormalities, cognitive deficits, hearing difficulties, and a variety of other medical problems. The Df1/+
hemizygous knockout mouse, a model for human 22q11DS, recapitulates many of the deficits observed in the human
syndrome including heart defects, impaired memory, and abnormal auditory sensorimotor gating. Here we show that
Df1/+ mice, like human 22q11DS patients, have substantial rates of hearing loss arising from chronic middle ear
infection. Auditory brainstem response (ABR) measurements revealed significant elevation of click-response
thresholds in 48% of Df1/+ mice, often in only one ear. Anatomical and histological analysis of the middle ear
demonstrated no gross structural abnormalities, but frequent signs of otitis media (OM, chronic inflammation of the
middle ear), including excessive effusion and thickened mucosa. In mice for which both in vivo ABR thresholds and
post mortem middle-ear histology were obtained, the severity of signs of OM correlated directly with the level of
hearing impairment. These results suggest that abnormal auditory sensorimotor gating previously reported in mouse
models of 22q11DS could arise from abnormalities in auditory processing. Furthermore, the findings indicate that
Df1/+ mice are an excellent model for increased risk of OM in human 22q11DS patients. Given the frequently
monaural nature of OM in Df1/+ mice, these animals could also be a powerful tool for investigating the interplay
between genetic and environmental causes of OM.
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Introduction
22q11.2 Deletion Syndrome (22q11DS, OMIM #188400),
also commonly known as DiGeorge Syndrome or Velo-Cardio-
Facial Syndrome, is a genetic disorder that results from an
approximately 1.5-3Mb congenital multigene deletion on the
long arm of chromosome 22, which includes the gene for T-Box
Transcription factor 1 (TBX1) [1,2]. 22q11DS occurs in 1:4000
live births, making it the most common interstitial deletion
syndrome and the second most common chromosomal
abnormality after Down's Syndrome [3]. Typical physical
findings in 22q11DS patients include defects in cardiovascular
[4], thymic, parathyroid and craniofacial [5] structures derived
from the pharyngeal arches and pouches [6]. In addition,
22q11DS is associated with high frequencies (80–100%) of
neurocognitive disabilities [7], and it is one of few cytogenetic
abnormalities that occurs in tandem with a psychiatric disease
[3]. The syndrome is one of the highest known risk factors for
schizophrenia, as 25-30% of 22q11DS patients develop
schizophrenia during adolescence or adulthood [8].
22q11DS is also a risk factor for development of otitis media
(OM) [9]. OM is inflammation of the middle ear cavity (MEC),
often presenting with pain and fever. It is the most common
disease in young children worldwide, occurring at least once
before the age of two in 90% of infants in the developed world
[10]. OM is typically classified as either acute or chronic. Acute
otitis media is associated with a bacterial infection and often
resolves spontaneously within three months. However, in some
cases acute OM is followed by otitis media with effusion (OME)
that can become chronic [11]. OME is characterized by
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excessive effusion that accumulates in the MEC, and the
absence of obvious signs of acute infection. Excessive effusion
often leads to conductive hearing loss, which in severe cases
can become permanent due to erosion of the middle ear
ossicles [12] . Even in less severe cases, conductive hearing
loss due to OME can interfere with speech and language
development. The usual treatment and also the most common
operation in the United Kingdom is the insertion of grommets
into the tympanic membrane to permit ventilation and drainage
of exudates from the MEC [13]. Risk factors for OM include
infection, altered immune status, exposure to tobacco smoke,
and anatomical defects such as cleft palate [14] . In addition,
although the pathogenesis of OM is multifactorial, a role for
genetic predisposition is increasingly recognized [15,16]. In
22q11DS, studies have shown that a majority of patients have
a history of chronic or recurrent OM [17,18].
The hemizygous Df1-knockout mouse (Df1/+) was
genetically engineered to be a model for human 22q11DS; it
carries a multigene deletion in a region of mouse chromosome
16 that is orthologous to the 22q11.2 region in humans [19,20].
Although the region is highly conserved, several ancestral
rearrangements have led to changes in gene order, and so the
deletion in Df1/+ mice encompasses 18 of the protein-encoding
genes deleted in human 22q11DS. Df1/+ mice have proven to
be an excellent model for major developmental defects in
human 22q11DS such as cardiovascular abnormalities [21] and
thymic or parathyroid defects [22], although no gross
craniofacial abnormalities such as cleft palate have been
reported. Furthermore, both Df1/+ mice and other mouse
models of 22q11DS have been found to show cognitive and
behavioural abnormalities associated with human 22q11DS
and schizophrenia, including reduced auditory sensorimotor
gating [23-25]. Modern tests of sensorimotor gating depend on
the ability to hear, and previous studies have presented some
evidence for normal hearing in Df1/+ mice and similar mouse
models [23-25]. However, mice heterozygous for Tbx1, one of
the genes involved in the multigene deletion and the most likely
candidate gene responsible for the pharyngeal arch-derived
defects in 22q11DS, have been shown to suffer frequent
middle ear inflammation with associated conductive hearing
loss [26].
Here, we aimed to resolve this discrepancy in the literature,
using auditory brainstem response (ABR) measurement to
assess hearing capability in adult Df1/+ mice and their WT
littermates. To obtain data from a large population of age-
matched Df1/+ and WT mice, we focused on measurement of
click-evoked ABR thresholds, a simple and rapid
electroencephalographic measure of peripheral and early
central auditory activity that could be obtained in vivo from
each ear for all animals in a litter in a single day. We found that
click-evoked ABR thresholds were significantly elevated in 48%
of the Df1/+ animals, often in only one ear. Anatomical and
histological analysis of the middle ear revealed a high
incidence of OME in Df1/+ mice, which correlated directly with
elevated ABR thresholds. We conclude that Df1/+ mice, like
human 22q11DS patients, are susceptible to otitis media and
conductive hearing loss. These results suggest that studies of
abnormal auditory sensorimotor gating in Df1/+ mice need to
be revisited using more sensitive assays for hearing loss, and
also that Df1/+ mice are a potentially powerful animal model for
studying the genetic and environmental causes of otitis media.
Results
Elevated ABR thresholds in both male and female Df1/+
mice
The auditory brainstem response is an
electroencephalographic signal arising from sound-evoked
activity in neuronal circuits of the ascending central auditory
pathway. ABRs evoked by click stimuli were recorded in 44
Df1/+ mice (24 male, 20 female) and 43 WT littermates (24
male, 19 female), ranging in age from 8 to 40 weeks old.
Measurements were taken once in each animal in either one or
both ears, under free-field conditions with an ear plug in the
opposite ear. Both left and right ears were tested in 31 of the
Df1/+ and 23 of the WT animals, and one ear only in 13 Df1/+
and 20 WT mice. The ABR database therefore consisted of a
total of 75 Df1/+ and 66 WT ABR recordings. Click ABR
thresholds were determined for each recording, and judged to
be the lowest click intensity at which characteristic peaks of the
ABR waveform could be observed (Figure S1).
Click ABR thresholds were significantly higher on average,
and also more variable, in both male and female Df1/+ mice
than in their gender-matched WT littermates (Figure 1A).
Median thresholds (and total ranges) were 35 (25-50) and 37.5
(30-55) dB SPL for male and female WT animals, respectively,
but 50 (30-75) and 50 (35-85) for male and female Df1/+ mice
from the same litters. Median thresholds therefore differed
significantly between recordings from Df1/+ and WT mice of the
same gender (Wilcoxon Mann-Whitney test, Df1/+ versus WT:
p=6x10-6 males, p=9x10-7 females), but not between males and
females of the same genotype (Wilcoxon Mann-Whitney test,
males versus females: p=0.3 Df1/+, p=0.5 WT). Similar results
were obtained when recordings from left or right ears were
considered separately.
ABR threshold distribution in Df1/+ mice appears
bimodal
Since there were no significant differences in click ABR
thresholds recorded from male and female animals of the same
genotype, we pooled data from male and female mice to
examine genotype differences in the threshold distributions
more closely (Figure 1B). The distribution of click ABR
thresholds recorded from Df1/+ mice was significantly different
from the distribution recorded from WT mice (Kolmogorov-
Smirnov test, p=5x10-8), even when the two distributions were
normalised to align the medians (Kolmogorov-Smirnov test on
median-normalised data, p=0.02). In fact, the Df1/+ threshold
distribution appeared bimodal, suggesting that ABR deficits
were perhaps restricted to a subset of Df1/+ animals.
To be conservative, we defined a click ABR deficit to be
present when the ABR threshold exceeded 55 dB SPL
(criterion threshold indicated by dashed lines in Figure 1A and
B), since 55 dB SPL was the highest threshold observed in
recordings from WT mice. By definition, none of the ABR
thresholds recorded in WT mice exceeded this criterion;
Hearing Loss in a Mouse Model of 22q11DS
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however, 38% of thresholds recorded from the ears of Df1/+
mice did. Since elevated ABR thresholds could occur either in
only one ear or in both ears, the percentage of affected animals
could in principle differ from the percentage of affected ears.
We investigated this issue with further analysis of ABR data
from the subset of animals for which both left and right ear ABR
recordings had been obtained.
ABR deficit in Df1/+ mice can be either monaural or
binaural
To determine whether click ABR thresholds tended to be
similar in the two ears, we compared left and right ABR
thresholds for the 31 Df1/+ and 23 WT animals for which ABR
recordings had been collected from both ears (Figure 2A). The
correlation between left and right ear ABR thresholds was
lower in Df1/+ than WT mice (Pearson's r=0.49, p=0.006 for
Df1/+ mice; r=0.68, p=0.0004 for WT mice), but not significantly
so (Fisher transformation test for difference in correlation
coefficients). Thus left and right ear ABR thresholds were
correlated in both groups of animals. However, among the
Df1/+ mice, 16 (52%) had no significant click ABR deficit in
either ear, 9 (29%) had a significant deficit in one ear, and 6
(19%) had deficits in both ears. Thus, 48% of the Df1/+ mice
had a click ABR deficit in at least one of the two ears, and the
deficit was monolateral in 60% of those affected animals. This
finding is suggestive of a conductive origin for the hearing loss,
because most causes of sensorineural hearing loss would be
expected to affect both ears.
ABR deficit in adult Df1/+ mice shows no age
dependence
The C57BL/6 background strain from which Df1/+ mice and
their WT littermates are derived is known to have age-related
sensorineural hearing loss, especially at high sound
frequencies [27,28]. Mutations can accelerate age-related
hearing loss, so we wondered if ABR deficits in Df1/+ mice
might worsen with age in adulthood. However, we found no
significant dependence of click ABR thresholds on age in
adulthood, for either Df1/+ or WT mice (Figure 2B). Similar
results were obtained whether the analysis was performed on
all recorded ABR thresholds as shown in Figure 2B, or on
thresholds from left ears or right ears separately. These results
demonstrate that click ABR deficits in Df1/+ animals cannot be
explained by aging-related effects, suggesting again that these
deficits are likely to be primarily conductive in origin. However,
since WT C57BL/6 animals would be expected to have age-
related hearing loss for high sound frequencies, the negative
results for WT animals also indicate that ABR thresholds for a
broadband click stimulus are not a sufficiently sensitive assay
to evaluate the possibility of high-frequency sensorineural
hearing loss in addition to conductive loss (see Discussion).
Figure 1.  Elevated ABR thresholds, and bimodal distribution of thresholds, in Df1/+ mice.  (A) Click ABR thresholds recorded
from individual ears in male and female WT (black) and Df1/+ (red) mice. Median ABR thresholds differed significantly between
Df1/+ and WT mice of the same gender (Wilcoxon Mann-Whitney test, Df1/+ versus WT: p=6x10-6 males, p=9x10-7 females), but not
between males and females of the same genotype (Wilcoxon Mann-Whitney test, males versus females: p=0.3 Df1/+, p=0.5 WT).
(B) Click ABR thresholds pooled across recordings from male and female animals, to illustrate the bimodal appearance of the Df1/+
ABR threshold distribution. Dashed lines indicate the criterion threshold for a significant click ABR deficit (see text).
doi: 10.1371/journal.pone.0080104.g001
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Adult Df1/+ mice have a high incidence of OM
To determine whether Df1/+ mice have middle ear problems,
we first examined middle ear anatomy and histology in 9 Df1/+
mice and their WT littermates. The 9 Df1/+ mice included 6
animals with confirmed ABR deficits and 3 mice that had not
undergone ABR testing; 2 of these 3 mice had a negative
Preyer reflex. MicroCT scans revealed no gross abnormalities
in middle ear anatomy in the Df1/+ mice compared to their WT
littermates, and there were no defects in the ossicular chain
(Figure S2). However, histological analysis demonstrated a
high incidence of OME in the Df1/+ animals (Figure 3E), with
frequent signs of inflammation such as effusion, capillary
hyperplasia, a thickened tympanic membrane and thickened
MEC mucosa (Figure 3F). Affected animals had effusion in one
or both ears and the effusion content varied with respect to
quantity of infiltrated and inflammatory cells. In some Df1/+
mice with severe OME, the Eustachian tube (ET) was infiltrated
by inflammatory cells. Examination of the mucociliary integrity
in Df1/+ mice with severe OM revealed increased mucus
production within the middle ear adjacent to the orifice where
the ET enters the MEC, suggesting increased goblet cell
density (Figure 3G compared to C). In Df1/+ mice displaying
mild OM, however, this increased mucus secretion was only
observed occasionally (data not shown).
Morphological changes in the MEC mucosa in Df1/+
mice with OM
To further investigate OM-associated changes in the
pseudostratified mucociliary epithelium lining the MEC, we
turned to scanning electron microscopy (SEM). Comparing the
density and distribution of cilia next to the opening of the ET,
we observed that WT and Df1/+ mice without infiltrated cells in
the MEC displayed a thick lawn of evenly distributed cilia
adjacent to a border region of unciliated epithelium (Figure 3D).
In Df1/+ mice with OME, however, cilia density was reduced
and the cilia were rarefied and shortened; in addition, the MEC
epithelium was swollen and partly covered in exudate (Figure
3H).
Elevation of ABR thresholds correlates with the
severity of OM in Df1/+ mice
To determine whether OM could account for click ABR
deficits in Df1/+ mice, we performed histological analysis of the
MEC on a set of adult littermates (5 Df1/+ and 1 WT, age 8
weeks) for which click ABRs had been recorded in both ears.
The WT mouse and 1 Df1/+ mouse had normal ABR thresholds
in both ears; 1 Df1/+ mouse had a slightly elevated ABR
threshold in one ear and a normal threshold in the other; 2
Df1/+ mice had a significantly elevated ABR threshold in one
ear and a normal or only slightly elevated threshold in the other
ear; and 1 Df1/+ mouse had significantly elevated thresholds in
Figure 2.  ABR deficit in Df1/+ mice is often monolateral, and shows no age dependence.  (A) Click ABR thresholds recorded
in left versus right ears, for WT (black) and Df1/+ (red) mice in which both ears were tested. Dashed line indicates criterion threshold
for a significant click ABR deficit. (B) Click ABR thresholds versus age, for all ABR recordings. Solid lines indicate best-fit regression
lines. Slopes were not significantly different from zero for recordings from either WT (black; slope 95% CI [-0.047, 0.072]) or Df1/+
(red; slope 95% CI [-0.072, 0.030]) animals. To ensure visibility of overlapped data points, zero-mean, 1 dB SPL standard-deviation
Gaussian noise was added to threshold data in both A and B for display.
doi: 10.1371/journal.pone.0080104.g002
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both ears. Data from these 6 littermates (12 ears) therefore
provided a perfect opportunity to test for a correlation between
elevation of click ABR thresholds and signs of OM in Df1/+
animals (Table 1).
Two measures of the severity of OM were used: presence of
effusion, and increased thickness of the middle ear mucosa.
Analysis was performed blind to genotype and was repeated by
multiple operators to ensure reliability of classifications.
As shown in Table 1 and Figure 4, Df1/+ ears for which click
ABR thresholds were most elevated (>70 dB SPL) had effusion
with more than 50% of infiltrated cells within the MEC (Table 1
and Figure 4D). These mice also displayed a severe thickening
of the ME mucosa, which could have produced physical
obstruction of movement of the ossicles (Figure 4G). In some
cases the epithelial thickness was observed to be up to 23
times higher than in WT littermates.
Df1/+ ears for which ABR recordings had revealed marginally
lower thresholds (60-70 dB SPL) displayed effusion with fewer
infiltrated cells and a less severe thickening of the mucosa
(Table 1 and Figure 4C), indicating a less advanced
inflammation. In these animals there was only limited tissue
around the ossicles (Figure 4F).
Df1/+ ears with normal or slightly elevated ABR thresholds
(40-45 or 50-55 dB SPL) showed either no effusion (Table 1
and Figure 4A) or a serous effusion only (Table 1 and Figure
4B) with no or mild thickening of the mucosa (Figure 4E or F).
Thus both the severity of effusion and the severity of mucosa
thickening were significantly correlated with elevation of click
ABR thresholds across the Df1/+ ears (Table 1; Spearman's
correlation test: rho=0.88, p=0.0007 for severity of effusion;
rho=0.75, p=0.013 for severity of mucosa thickening). The two
ears from the WT animal (2* in Table 1), for which both ABR
thresholds were normal, had no effusion (Figure 4A) and
normal ME mucosa (Figure 4E).
In addition to these 6 littermates, we also examined 5 more
animals which also underwent hearing tests, and we found the
same correlation between hearing loss and OM in those
additional animals. No evidence of ossicle erosion was
observed, but such erosion might only be present in older mice
after repeated bouts of OM.
Further observations
Bacteriology.  Bacteriological analysis of middle ear swabs
obtained from both ears of 4 Df1/+ mice revealed, in 4 out of
the 8 ears, the presence of commensal bacteria and
opportunistic pathogens that do not normally cause infections
in a healthy ear. One mouse had scant growth of Escherichia
coli in both ears; another had moderate growth of Lactococcus
lactis spp lactis in one ear; a third was found to have scant
growth of Pantoea spp in one ear. No fungi or yeast were
isolated from any of the samples. These results suggest that
OM in Df1/+ mice is unlikely to be caused by unusual
susceptibility to a specific pathogen; rather, any bacterial
Figure 3.  Morphological changes in MEC mucosa and epithelium in Df1/+ mice.  (A-C, E-G) Frontal trichrome-stained sections
from 11.5-week-old mice showing the middle ear cavity. (D, H) SEM images of middle ear epithelium. (A-D) WT. (E-H) Df1/+ with
signs of OM. (A) The middle ear cavity is air-filled in the WT. (B) The mucosa is a thin layer lining the auditory bulla. (C) At the
entrance of the Eustachian tube (ET) high levels of alcian blue staining are observed indicating mucin production. Further into the
middle ear away from the orifice, staining is less distinct in the WT (arrowheads). (D) A thick lawn of cilia is observed overlying the
epithelium near the ET orifice. (E) In Df1/+ mice the middle ear cavity is filled with effusion (arrow). (F) Df1/+ mice show signs of
inflammation such as effusion with infiltrated inflammatory cells (asterix), a thickened mucosa (arrow) and hypervascularisation
(arrowhead). (G) In addition, increased alcian blue staining is observed within the middle ear at a distance from the ET indicating
increased mucin production in Df1/+ mice (compare C and G, arrowheads). (H) Df1/+ mice with OM show reduced numbers of cilia
that appear shortened and rarefied. Dorsal is top in A-C, E-G. Scale bar: 500 μm (A, E), 100 μm (B, C, F, G).
doi: 10.1371/journal.pone.0080104.g003
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infection of the middle ear in Df1/+ mice is probably a
secondary opportunistic process.
Hair cell density in the organ of Corti.  To address the
possibility that elevated ABR thresholds in Df1/+ mice might
arise from sensorineural as well as conductive hearing loss, we
examined the sensory epithelium of the inner ear in 6 Df1/+
and 5 WT mice. There was no evidence for significant loss of
hair cells sufficient to account for the elevated ABR thresholds
in Df1/+ relative to WT mice. Moreover, the density of hair cells
in the cochlea appeared normal in both ears of Df1/+ animals
with monolateral hearing loss (Figure S3). On the basis of our
analysis, we cannot entirely rule out the possibility of subtle
inner ear abnormalities in Df1/+ mice, especially given that
severe OM can sometimes affect the inner ear. However, we
can conclude that the observed click ABR deficit in Df1/+ mice
does not arise from hair cell loss.
Discussion
Here we have shown that Df1/+ mice are susceptible to
conductive hearing loss and otitis media, which are also
common consequences of the human 22q11.2 deletion that the
mice were genetically engineered to model. Mouse models of
22q11DS such as the Df1/+ mouse have attracted great
interest not only as a tool for investigating the origins of various
defects and disabilities associated with this relatively common
Table 1. Correlation between severity of OM and click ABR
thresholds in ears from six littermates (5 Df1/+, 1 WT).
Signs of OM Click ABR Thresholds
Measure Severity Normal Slightly Elevated Severely
  
(<50
dB
SPL)
elevated (60-70dB SPL) Elevated
   (50-55 dBSPL)  
(>70 dB
SPL)
Effusion No effusion 3+2* 1 0 0
 Serous effusion 1 1 0 0
 Effusion with <50%infiltrated cells 0 0 2 0
 Effusion with >50%infiltrated cells 0 0 0 2
Mucosa
thickening
No thickening
(0.077-0.15mm) 2+2* 1 0 0
 Mild thickening(0.151-0.49mm) 2 1 1 0
 Severe thickening(0.491-0.827mm) 0 0 1 2
Degree of effusion with infiltrated cells and thickening of the middle ear mucosa
directly correlates with elevation of ABR thresholds in ears from the Df1/+
littermates (Spearman's correlation test: rho=0.88, p=0.0007 for severity of
effusion; rho=0.75, p=0.013 for severity of mucosa thickening). Ears from the WT
littermate, indicated by the asterix (*) , had normal ABR thresholds and no signs of
OM.
doi: 10.1371/journal.pone.0080104.t001
chromosomal disorder, but also as a means of gaining insight
into the pathogenesis of schizophrenia, for which 22q11DS is
one of the most significant known risk factors. In the context of
this previous research, the present study makes three distinct
contributions.
First, the results suggest a resolution to a discrepancy in the
literature between previous studies reporting normal hearing in
the Df1/+ and Df(16)A/+ mouse models of 22q11DS [23-25]
and studies documenting a high incidence of middle ear
disease in mice heterozygous for the gene Tbx1 [26], which is
included in the Df1/+ and Df(16)A/+ deletion regions. The
previous evidence for normal hearing in mouse models of
22q11DS came from supplementary controls in studies of
prepulse inhibition (PPI) of acoustic startle. In one study [23],
thresholds for acoustic startle were observed to be slightly
lower, and startle amplitudes slightly higher, in Df1/+ mice than
in their WT littermates; in another study [25], similar results
were reported for Df(16)A/+ mice, which have a larger deletion
region than Df1/+ mice. Both studies therefore concluded that
there was no evidence for reduction in hearing sensitivity in
these mice. However, under some circumstances, mice with
partial hearing loss can show reduced startle thresholds and
elevated startle amplitudes in acoustic startle testing [29],
perhaps because central auditory adaptation to the reduction in
peripheral input leads to hyperacusis for loud sounds. Better
evidence for normal hearing in Df1/+ mice was provided in [24]
based on frequency-specific distortion-product otoacoustic
emission (DPOAE) testing, which is generally an excellent
means of detecting peripheral auditory abnormalities including
middle ear problems. However, the DPOAE testing in that
study was performed on only 6 Df1/+ mice, and apparently only
on one ear in each animal. Given the intermittent nature of the
ABR deficit and OM observed in the present study (48% of
Df1/+ animals, but only 38% of Df1/+ ears tested), it is possible
that this sample size was too small. We therefore suggest that
previous evidence for normal hearing in Df1/+ and Df(16)A/+
mice was inconclusive, and that all mouse models of 22q11DS
involving deletion of Tbx1 may have a high incidence of
conductive hearing loss.
The second contribution of the present work is to show that
previous reports of abnormal auditory sensorimotor gating in
mouse models of 22q11DS need to be re-examined to
determine whether abnormalities in auditory processing alone
might account for the results. Impaired auditory sensorimotor
gating, quantified as a reduction in PPI of acoustic startle, is
considered an important endophenotype for risk of
schizophrenia. Reduced PPI of acoustic startle has been
reported both in human 22q11DS patients [30] and in mouse
models of 22q11DS [23-25]. However, as discussed above, the
high incidence of conductive hearing loss and otitis media in
Df1/+ mice could itself lead to differences between Df1/+ and
WT animals in PPI of acoustic startle. Moreover, although we
found no abnormalities in hair-cell density that could account
for the observed elevation of click ABR thresholds in Df1/+
mice, it is possible that Df1/+ mice have more subtle
sensorineural hearing deficits, especially given that Tbx1 is
involved in inner ear development [31]. The possibility of such
abnormalities could be explored further in the future with tone-
Hearing Loss in a Mouse Model of 22q11DS
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evoked ABR measurements or distortion-product otoacoustic
emission (DPOAE) testing, which are more sensitive assays for
frequency-specific hearing loss than click-evoked ABR
measurements.
The final contribution of this work is to introduce the Df1/+
mouse as a powerful model system for investigating the
pathogenesis of OM in 22q11DS and also more generally.
Hearing loss is prevalent among human 22q11DS patients [32],
and is almost always related to middle ear infection. In one
study, chronic or recurrent otitis media was reported in 52% of
22q11DS patients [18]; in another 88% had otitis media, 53%
had conductive hearing loss, and 39% required surgical
implantation of ventilation tubes to drain the middle ear [17]. In
these patients the causes of the OM have been proposed to be
multifactorial involving immune deficiency, palatal abnormalities
and Eustachian tube dysfunction [18]. The high incidence of
conductive hearing loss and otitis media in Df1/+ mice indicates
that these animals can be used to tease apart the causes of
frequent OM in 22q11DS patients. Moreover, the prevalence of
monolateral ABR deficits and OM in Df1/+ mice creates
opportunities for within-animal controls, making the animals a
potentially powerful tool for testing hypotheses about the
causes of OM. Studies of the mechanism by which genetic
predispositions cause OM have been performed in other
mouse models, such as the heterozygous Fbxo11 mouse and
Eya4 knockout mouse. Fbxo11 is expressed in the lining of the
middle ear cavity and has been proposed to affect epithelial
inflammatory events in the ear [33]. In contrast, in the Eya4
mouse the morphology of the Eustachian tube and angle of
connection to the middle ear have been shown to be defective,
potentially causing ear clearance problems [34]. Tbx1 has been
shown to be expressed in the endoderm of the developing
pharyngeal arches and Tbx1 null mice have a hypoplastic
pharynx [35,36]. As the Eustachian tube arises from the
endodermally derived first pharyngeal pouch it is therefore
tempting to speculate that a subtle early defect in patterning of
the endoderm might be responsible for the high incidence of
OM in Df1/+ and Tbx1 heterozygous mice. Our ongoing efforts
to pinpoint the causes of otitis media in Df1/+ mice are
therefore focusing on the possibility of abnormalities in the
morphology of the Eustachian tube and/or the other
endodermally derived tissues of the middle ear [37].
In conclusion: Df1/+ mice, like human 22q11DS patients, are
susceptible to otitis media and conductive hearing loss, which
affect nearly half the animals but often in only one ear. The
findings suggest that abnormal auditory sensorimotor gating
previously reported in mouse models of 22q11DS could arise
from abnormalities in auditory processing. More broadly, the
results indicate that Df1/+ mice are an important model system
for investigating the causes of OM in both 22q11DS patients
and the many children worldwide who suffer from chronic
middle ear infections.
Figure 4.  The severity of OM correlates with the degree of hearing loss in Df1/+ mice (see also Table 1).  (A-G) Frontal
trichrome-stained sections from adult mice showing the graded severity of effusion in Df1/+ middle ear cavities (A-D) and thickened
mucosa around the head of the malleus (E-G). Least severe conditions are displayed on the left hand side panels with increasing
severity towards the right hand side panels. (A) No effusion, (B) serous effusion, (C) effusion with <50% infiltrated cells and (D)
effusion with >50% infiltrated cells. (E) No thickening, (F) mild thickening and (G) severe thickening of the mucosa around the head
of the malleus. Dorsal is top. Scale bar: 500 μm (A-D), 100 μm (E-G).
doi: 10.1371/journal.pone.0080104.g004
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Materials and Methods
Ethics statement
All in vivo experiments were conducted in accordance with
the United Kingdom's Animal (Scientific Procedures) Act of
1986, under a project licence approved by the UK Home Office.
Animals
The Df1/+ mouse line had been maintained on a C57BL/6
background for a minimum of 10 generations prior to the
analyses. The Df1 deletion itself was engineered on a 129S5
SvEvBrd genetic background [21].
Hearing tests
Auditory brainstem response measurement.  ABR testing
was performed in a sound isolation booth (Industrial Acoustics
Company, Inc.). Mice were anaesthetised with ketamine and
medetomidine. Body temperature was maintained at 37-38°C
using a homeothermic blanket (Harvard Apparatus). Subdermal
needle electrodes (Rochester Medical) were inserted under the
skin with positive electrode at the vertex, negative electrode
near the ear being tested, and ground electrode near the
opposite ear (which was blocked with a sound-attenuating
earplug). For most animals, ABR recordings were obtained
from both the left and right ears in turn, with an earplug in the
ear opposite to that under test (to ensure monaural stimulus
presentation).
Auditory stimuli were presented via a free-field speaker (FF1)
from Tucker-Davis Technologies (TDT). Speaker output was
calibrated before each set of experiments using a Bruel & Kjaer
¼ inch microphone (4939), placed at the location of the ear to
be tested. Stimulus generation and data acquisition were
accomplished using hardware from TDT (RX6 and RX5 signal
processors, RA4LI and RA16SD signal amplifiers, PA5
attenuator, and SA1 speaker amplifier), a custom low-pass
filter designed to remove attenuation switching transients, and
software from TDT (Brainware) and Mathworks (Matlab).
Stimuli were 50 μs monophasic clicks ranging in sound level
from 0 to 90 dB SPL, presented at a rate of 20 clicks/sec. ABR
recordings typically included 500 repeats of click stimuli
presented over a 20-80 dB SPL range at 20 dB intensity
increments, followed by 1000 repeats of click stimuli presented
over a smaller intensity range at 5 dB intensity increments. The
threshold was defined to be the lowest click intensity evoking a
clear and characteristic deflection of the ABR wave that was at
least as large as the time-dependent standard error in the
mean wave at that sound intensity.
Preyer reflex assessment.  A few of the mice used for
studies of middle ear anatomy and histology did not undergo
ABR measurement due to time constraints, and instead were
tested for a Preyer reflex. The Preyer reflex is a flick of the
pinnae evoked by a transient loud sound. To present such
sounds, we used a custom-built click box (MRC Institute of
Hearing Research, Nottingham, UK) emitting a brief 18.5 kHz
tone burst with intensity 95-105 dB SPL at the distances
typically used for testing. Since the Preyer reflex is somewhat
unreliable even in animals with normal hearing, we judged the
Preyer reflex to be negative only if an animal showed no Preyer
reflex across several presentations of the sound.
Middle ear analyses
Histology.  Mouse heads were fixed in 4%
paraformaldehyde (PFA) overnight at 4°C and then decalcified
in EDTA Solution (67.5% EDTA, 7.5% PBS and 25% PFA
(4%)). The tissue was then dehydrated through a methanol
series and isopropanol and cleared in tetrahydronaphthalene
before embedding in paraffin wax. The 9 μm frontal sections
were mounted on Superfrost Plus Slides, dewaxed in
Histoclear, rehydrated through IMS, stained with 1% Alcian
blue in 3% acetic acid pH2.5, Ehrlich’s haematoxylin, and 0.5%
Sirius Red in saturated picric acid, and then mounted in DPX.
Slides were imaged on a Nikon Digital Sight Camera.
Measurement of mucosa thickness was performed using Image
J software.
Scanning electron microscopy.  The temporal bones of
adult mice were dissected and the middle ear mucosa revealed
by removing the outer ear, eardrum, tympanic ring and the
malleus and incus. These were then fixed in 2.5%
gluteraldehyde in 0.15M cacodylate buffer (pH7.2) overnight at
4°C, and washed and postfixed in 1% osmium tetroxide. Next
specimens were dehydrated through an ethanol series and
dried using a Polaron E3000 critical point dryer. After mounting
and coating with gold (Emitech K550X sputter coater), the
surface of the mucosa was examined and images recorded
using a Hitachi S-3500N scanning electron microscope (SEM)
operated at 10kV in high vacuum mode.
MicroCT reconstruction.  Micro computerized tomography
(microCT) was used for the three-dimensional analysis of Df1/+
and WT middle ear morphology.
Inner ear analysis
Cochleae were fixed in 4% PFA in PBS for 2 hrs, then
decalcified in 4% EDTA in PBS at pH7.4 for 48 hrs at 4°C. The
organ of Corti was extracted in half-turn segments,
permeabilised in 0.5% Triton X-100 for 15 min, and incubated
with fluorescently conjugated phalloidin at 1 μg/ml for 2 hrs.
Phalloidin labels filamentous actin and therefore delineates
both hair cell stereocilia and intercellular junctions at the
luminal surface of the organ of Corti. Segments were mounted
on slides using an anti-photobleaching agent (Vectashield) that
also contained DAPI (VectaLabs) to label cell nuclei. Slides
were then examined and images taken with a confocal
microscope (Zeiss) and viewed for analysis through LSM
browser (Zeiss).
Supporting Information
Figure S1.  Example click ABR waveforms from a WT
mouse (A) and a Df1/+ littermate (B), both male and 29
weeks old. Left plots show ABR waveforms evoked by clicks
at 20, 40, 60 and 80 dB SPL, averaged over 500 trials for each
stimulus. Right plots show ABR waveforms evoked by clicks
presented over a smaller intensity range and at finer intensity
resolution, averaged over 1000 trials per stimulus. Grey
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shading around black lines indicates standard error of the
mean across trials. Threshold was judged to be 30 dB SPL for
the WT mouse (A), and 65 dB SPL for the Df1/+ animal (B).
(TIF)
Figure S2.  Middle ear structure in adult WT and Df1/+
mice. MicroCT reconstruction of the bony auditory bulla
surrounding the middle ear cavity, with ossicles shown in
pseudocolor. No differences in morphology of the middle ear
and the ossicular chain were observed between (A) WT and
(B) Df1/+ mice. Scale bar: 1mm.
(TIF)
Figure S3.  Whole-mount organ of Corti segments taken
from the basal turns of the left (A) and right (B) cochleae in
a male Df1/+ mouse (age 24 weeks) with pronounced
monolateral hearing loss. ABR thresholds measured in vivo
were 65 dB SPL for the left ear and 35 dB SPL for the right ear.
In both ears, the sensory epithelium appears relatively normal
for an animal of this age, with only the occasional hair cell
missing. Red, phalloidin stain (highlighting filamentous actin in
hair cells); blue, DAPI (highlighting cell nuclei). Scale bars: 20
μm.
(TIF)
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